{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:52Z","timestamp":1789053952844,"version":"build-2803163510"},"reference-count":45,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Cutaneous and Ocular Toxicology"],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.1080\/15569527.2024.2361334","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T17:14:15Z","timestamp":1717002855000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of eye irritation potential of experimental cosmetic formulations containing glycolic acid, salicylic acid and ethanol using the Bovine Corneal Opacity and Permeability Assay"],"prefix":"10.1080","volume":"43","author":[{"given":"R.","family":"Labib","sequence":"first","affiliation":[{"name":"Avon Global Research and Development, Suffern, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Cantrell","sequence":"additional","affiliation":[{"name":"Institute for In Vitro Sciences, Inc. (IIVS), Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-E.","family":"Costin","sequence":"additional","affiliation":[{"name":"Institute for In Vitro Sciences, Inc. (IIVS), Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. L.","family":"Milac","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry of the Romanian Academy, Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Raabe","sequence":"additional","affiliation":[{"name":"Institute for In Vitro Sciences, Inc. (IIVS), Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gettings","sequence":"additional","affiliation":[{"name":"Avon Global Research and Development, Suffern, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2010.12.003"},{"key":"e_1_3_3_3_1","unstructured":"OECD. Test No. 437: Bovine Corneal Opacity and Permeability test method for identifying i) Chemicals inducing serious eye damage and ii) Chemicals not requiring classification for eye irritation or serious eye damage; 2023. Available from: https:\/\/www.oecd-ilibrary.org\/docserver\/9789264203846-en.pdf?expires=1717159293&id=id&accname=guest&checksum=7F088AEE446C2816B5E20C8C1E4F04B6. Note: OECD TG 437 was updated in 2023 but no major changes have been made which would affect the assay conduct or interpretations included in this manuscript."},{"key":"e_1_3_3_4_1","unstructured":"ECHA. Guidance on the application of the CLP criteria. Guidance to Regulation (EC) No 1272\/2008 on classification labeling and packaging (CLP) of substances and mixtures version 5.0; 2017. Available from: https:\/\/echa.europa.eu\/documents\/10162\/23036412\/clp_en.pdf\/58b5dc6d-ac2a-4910-9702-e9e1f5051cc5"},{"key":"e_1_3_3_5_1","unstructured":"NIH. Newly approved ocular safety methods reduce animal testing; 2008."},{"key":"e_1_3_3_6_1","unstructured":"US EPA. Use of an alternate testing framework for classification of eye irritation potential of EPA pesticide products; 2015: 1\u201339."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569529609048870"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581816651606"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/faat.1995.1071"},{"issue":"1","key":"e_1_3_3_10_1","first-page":"188","article-title":"An histological analysis of damage to bovine corneas in vitro by selected ocular toxicants","volume":"54","author":"Curren RD","year":"2000","unstructured":"Curren RD, Evans MG, Raabe HA, et\u00a0al. An histological analysis of damage to bovine corneas in vitro by selected ocular toxicants. Toxicol. 2000;54(1):188.","journal-title":"Toxicol"},{"issue":"1","key":"e_1_3_3_11_1","first-page":"107","article-title":"Observations on the use of the bovine corneal opacity and permeability (BCOP) assay to evaluate the eye irritation potential of prototype cosmetic formulations containing salicylic acid, glycolic acid and ethanol","volume":"3","author":"Labib R","year":"2014","unstructured":"Labib R, Gilberti E, Costin G-E, et\u00a0al. Observations on the use of the bovine corneal opacity and permeability (BCOP) assay to evaluate the eye irritation potential of prototype cosmetic formulations containing salicylic acid, glycolic acid and ethanol. ALTEX Proc. 2014;3(1):107\u2013108.","journal-title":"ALTEX Proc"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/109158189801700101"},{"key":"e_1_3_3_13_1","unstructured":"Scientific Committee on Consumer Safety (SCCS). Opinion on salicylic acid (CAS 69-72-7). Submission 1. Adopted by written procedure on December 21 2018; [cited 2023 May 9]. https:\/\/ec.europa.eu\/health\/sites\/health\/files\/scientific_committees\/consumer_safety\/docs\/sccs_o_223.pdf. Last Updated 2019."},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10915818809078712"},{"key":"e_1_3_3_15_1","unstructured":"Cosmetic Ingredient Review. Safety assessment of glycerin as used in cosmetics; 2014. p. 1\u201319."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581816651606"},{"key":"e_1_3_3_17_1","volume-title":"Office of pesticide programs","author":"Redden JC","year":"2009","unstructured":"Redden JC, Perry MJ, Leighton T, et\u00a0al. 2009. Voluntary pilot program to evaluate use of non-animal testing approach to EPA labeling for eye irritation for certain antimicrobial products with cleaning claims. Office of pesticide programs. Washington, DC: US Environmental Protection Agency."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2002.1551"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/15569520500536626"},{"issue":"6","key":"e_1_3_3_20_1","first-page":"922","article-title":"Area and depth of surfactant-induced corneal injury correlates with cell death","volume":"39","author":"Jester JV","year":"1998","unstructured":"Jester JV, Li HF, Petroll WM, et\u00a0al. Area and depth of surfactant-induced corneal injury correlates with cell death. Investig Ophthal Vis Sci. 1998;39(6):922\u2013936.","journal-title":"Investig Ophthal Vis Sci"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/019262339602400403"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120924"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14010134"},{"issue":"4","key":"e_1_3_3_24_1","first-page":"247","article-title":"The CTFA evaluation of alternatives program: an evaluation of in vitro alternatives to the draize primary eye irritation test (phase 1) hydro-alcoholic formulations; (part 2) data analysis and biological significance","volume":"4","author":"Gettings S","year":"1991","unstructured":"Gettings S, Teal J, Bagley D, et\u00a0al. The CTFA evaluation of alternatives program: an evaluation of in vitro alternatives to the draize primary eye irritation test (phase 1) hydro-alcoholic formulations; (part 2) data analysis and biological significance. In Vitro Toxicol. 1991;4(4):247\u2013288.","journal-title":"In Vitro Toxicol"},{"key":"e_1_3_3_25_1","unstructured":"SCCNFP. Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for consumers concerning salicylic acid. SCCNFP\/0522\/01; 2002."},{"key":"e_1_3_3_26_1","first-page":"21","article-title":"Chemical burns of the eye","volume":"44","author":"Villard H.","year":"1927","unstructured":"Villard H. Chemical burns of the eye. Arch Ophthalmol. 1927;44:21\u201340; 93-111; 167-177; 222\u2013223.","journal-title":"Arch Ophthalmol"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027292"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_365_18"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2010.521536"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2009.05.019"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091978"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2003.10.025"},{"key":"e_1_3_3_33_1","unstructured":"Campbell PS Chandrasekaran SK. US Patent 4379454. Dosage for coadministering drug and percutaneous absorption enhancer; 1983."},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(85)90035-5"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1015832903398"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.25.134"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600761004"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(87)90065-4"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016329000518"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1015879925147"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-5173(99)00055-1"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5173(95)04328-4"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1993.tb05567.x"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-2333(95)00101-8"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(98)00039-5"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600730831"}],"container-title":["Cutaneous and Ocular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15569527.2024.2361334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T18:41:07Z","timestamp":1727203267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15569527.2024.2361334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7,2]]}},"alternative-id":["10.1080\/15569527.2024.2361334"],"URL":"https:\/\/doi.org\/10.1080\/15569527.2024.2361334","relation":{},"ISSN":["1556-9527","1556-9535"],"issn-type":[{"value":"1556-9527","type":"print"},{"value":"1556-9535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icot20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}